Treatment Information

Back

Lung Cancer treatment details. Chemotherapy.

NHO Shikoku Cancer Center, Matsuyama, Japan.

Survival: monthsCountry:Japan
Toxiciy Grade:5City/State/Province:Matsuyama
Treatments:ChemotherapyHospital:NHO Shikoku Cancer Center
Drugs:Journal:Link
Date:Jan 2012

Description:

Patients:
This phase II study involved 31 previously treated non-small cell lung cancer patients with a median age of 66 years; 21 were males.

Treatment:
Patients were treated with the chemotherapy agents irinotecan and amrubicin.

Toxicities:
There was one reported treatment-related death due to neutropenia with fever. Grade 4 leucopenia, diarrhea, and infection were also reported.

Results:
The median overall survival was 14.2 months.

Correspondence: Dr. Katsuyuki Hotta; email: [email protected]



Back